The National Institute of Health and Care Excellence (NICE) have published new or updated guidance for the month of November 2017. This month there are three guidelines that impact upon primary care.
The Bipolar disorder clinical guideline has been updated. It covers recognising, assessing and treating bipolar disorder (formerly known as manic depression) in children, young people and adults. The recommendations apply to bipolar I, bipolar II, mixed affective and rapid cycling disorders. It aims to improve access to treatment and quality of life in people with bipolar disorder. The guideline has been updated with footnotes containing current medication advice and some research recommendations have been stood down.
The Familial hypercholesterolaemia clinical guideline has been updated. It covers identifying and managing familial hypercholesterolaemia (FH), a specific type of high cholesterol that runs in the family, in children, young people and adults. It aims to help identify people at increased risk of coronary heart disease as a result of having FH. The evidence for case finding and diagnosis, identification using cascade testing, and management using statins has been reviewed and some recommendations have been amended.
The Glaucoma guideline has been published. It covers diagnosing and managing glaucoma in people aged 18 and over. It includes recommendations on testing and referral (case-finding) for chronic open angle glaucoma and ocular hypertension, and on effective diagnosis, treatment and reassessment to stop these conditions progressing.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.
|« SMC Update - November 2017||Drug Safety Update - November 2017 »|